iBio, Inc.
IBIO
$0.818
$0.0253.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.42% | -2.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.63% | 12.49% | |||
| Operating Income | -10.41% | -7.62% | |||
| Income Before Tax | -11.39% | -9.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.39% | -9.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.39% | -9.40% | |||
| EBIT | -10.41% | -7.62% | |||
| EBITDA | -11.13% | -7.95% | |||
| EPS Basic | -3.14% | -3.42% | |||
| Normalized Basic EPS | -3.15% | -3.43% | |||
| EPS Diluted | -3.14% | -3.42% | |||
| Normalized Diluted EPS | -3.15% | -3.43% | |||
| Average Basic Shares Outstanding | 7.99% | 5.78% | |||
| Average Diluted Shares Outstanding | 7.99% | 5.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||